• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Metabolic Disorders Follow-up Program

    Although the Newborn Metabolic Screen is still commonly called the “PKU” test, the testing has been expanded to include over 50 different conditions. These conditions include:
    • Inability to break down the sugar in breast milk and most formulas
    • Inability to break down different proteins
    • Inability to break down different fats for energy
    • Presence of abnormal red blood cells or sickle cell disease
    • Abnormal thyroid function (congenital hypothyroidism)
    • Abnormal adrenal glands (congenital adrenal hyperplasia)
    • Cystic fibrosis
     
    The goal of newborn metabolic screening is to identify babies who may have one of these conditions as soon as possible to help prevent problems. Babies who are born and live in the State of Maryland are screened in the hospital 24-48 hours after birth and again in their pediatrician’s office at about 2 weeks of age.
     
    To learn more about newborn metabolic screening, click on the links below.
     
     
    For Parents

    For Providers

     
     
    Newborn Screening
    Follow-up of Abnormal Results:
     
    Nurse Consultant:
    Johnna Watson, RN,BSN
    443-681-3916
     
    Nurse Consultant:
    Mary Jo Harris, RN,MS
    443-681-3918
     
    Nurse Consultant:
    Linda Lammeree, RN,MA
    443-681-3917
     
    Medical Director
    Deborah Badawi, MD
    410-767-5592